Citation Impact
Citing Papers
2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults
2013 Standout
Management Guidelines for Children with Thyroid Nodules and Differentiated Thyroid Cancer
2015 Standout
The relationship between high density lipoprotein subclass profile and plasma lipids concentrations
2010
Differential effects of HDL subpopulations on cellular ABCA1- and SR-BI-mediated cholesterol efflux
2005
The lipoprotein subfraction profile: heritability and identification of quantitative trait loci
2007
Therapeutic elevation of HDL-cholesterol to prevent atherosclerosis and coronary heart disease
2006
Relationship between plasma HDL subclasses distribution and lipoprotein lipase gene HindIII polymorphism in hyperlipidemia
2005
Effects of Torcetrapib in Patients at High Risk for Coronary Events
2007 Standout
Hypomorphic Mutation in the Site-1 Protease Mbtps1 Endows Resistance to Persistent Viral Infection in a Cell-Specific Manner
2011 StandoutNobel
Characteristics of High-density Lipoprotein Subclasses Distribution for Subjects with Desirable Total Cholesterol Levels
2011
Macrophages in the Pathogenesis of Atherosclerosis
2011 Standout
High-density lipoproteins as therapeutic targets
2005
Relationship between plasma lipid concentrations and HDL subclasses
2004
Alterations of high-density lipoprotein subclasses in endogenous hypertriglyceridemia
2005
A novel homozygous mutation in CETP gene as a cause of CETP deficiency in a caucasian kindred
2009
Plasma pre β-HDL formation is decreased by atorvastatin treatment in type 2 diabetes mellitus: Role of phospholipid transfer protein
2009
Relation of Increased Prebeta-1 High-Density Lipoprotein Levels to Risk of Coronary Heart Disease
2011
Clinical utility of inflammatory markers and advanced lipoprotein testing: Advice from an expert panel of lipid specialists
2011
Fibroblast cholesterol efflux to plasma from metabolic syndrome subjects is not defective despite low high-density lipoprotein cholesterol
2008
Hydrogen sulphide and its therapeutic potential
2007 Standout
Niacin therapy in atherosclerosis
2004
Laboratory investigation of dysfunctional HDL
2011
Progress and challenges in translating the biology of atherosclerosis
2011 StandoutNature
Multiple actions of high-density lipoprotein
2008
High-density lipoproteins: A consensus statement from the National Lipid Association
2013
The impact of plasma triglyceride and apolipoproteins concentrations on high-density lipoprotein subclasses distribution
2011
Cholesterol Efflux Capacity, High-Density Lipoprotein Function, and Atherosclerosis
2011 Standout
Reduced high-density lipoprotein 2b in non-obese type 2 diabetic patients analysed by a microfluidic chip method in a case–control study
2009
Antiretroviral Treatment of Adult HIV Infection
2012 Standout
High-Density Lipoprotein Subfractions - What the Clinicians Need to Know
2013 Standout
Pharmacokinetics, Metabolism, and Excretion of Anacetrapib, a Novel Inhibitor of the Cholesteryl Ester Transfer Protein, in Rats and Rhesus Monkeys
2009
Biological activities of HDL subpopulations and their relevance to cardiovascular disease
2011
Functionally Defective High-Density Lipoprotein: A New Therapeutic Target at the Crossroads of Dyslipidemia, Inflammation, and Atherosclerosis
2006 Standout
Hyperhomocysteinemia due to cystathionine beta synthase deficiency induces dysregulation of genes involved in hepatic lipid homeostasis in mice
2006
Value of High-Density Lipoprotein (HDL) Subpopulations in Predicting Recurrent Cardiovascular Events in the Veterans Affairs HDL Intervention Trial
2005
2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults
2013 Standout
HDL, ABC Transporters, and Cholesterol Efflux: Implications for the Treatment of Atherosclerosis
2008
Effects of Cholesteryl Ester Transfer Protein Inhibition on High-Density Lipoprotein Subspecies, Apolipoprotein A-I Metabolism, and Fecal Sterol Excretion
2005
Human immunodeficiency virus infection and macrophage cholesterol metabolism
2006
Alterations in the High Density Lipoprotein Phenotype and HDL‐Associated Enzymes in Subjects with Metabolic Syndrome
2008
Next Generation of Fluorine-Containing Pharmaceuticals, Compounds Currently in Phase II–III Clinical Trials of Major Pharmaceutical Companies: New Structural Trends and Therapeutic Areas
2016 Standout
Niacin therapy in atherosclerosis
2005
Pathophysiology of Type 2 Diabetes Mellitus
2020 Standout
Quantitative Serum Nuclear Magnetic Resonance Metabolomics in Cardiovascular Epidemiology and Genetics
2015 Standout
2016 ESC/EAS Guidelines for the Management of Dyslipidaemias
2016 Standout
Plasma Levels of HDL Subpopulations and Remnant Lipoproteins Predict the Extent of Angiographically-Defined Coronary Artery Disease in Postmenopausal Women
2008
Evaluation and Treatment of Hypertriglyceridemia: An Endocrine Society Clinical Practice Guideline
2012
Paradoxical Association of Enhanced Cholesterol Efflux With Increased Incident Cardiovascular Risks
2013
The Controversial Role of Human Gut Lachnospiraceae
2020 Standout
2016 ESC/EAS Guidelines for the Management of Dyslipidaemias
2016 Standout
Torcetrapib Differentially Modulates the Biological Activities of HDL2 and HDL3 Particles in the Reverse Cholesterol Transport Pathway
2008
Interruption of Antiretroviral Therapy and Risk of Cardiovascular Disease in Persons with HIV-1 Infection: Exploratory Analyses from the SMART Trial
2008
Works of Caitlin E. Cox being referenced
Protease inhibitor-based HAART, HDL, and CHD-risk in HIV-infected patients
2005
Apolipoprotein composition of HDL in cholesteryl ester transfer protein deficiency
2004
Change in α 1 HDL Concentration Predicts Progression in Coronary Artery Stenosis
2003
LpA-I, LpA-I:A-II HDL and CHD-risk: The Framingham Offspring Study and the Veterans Affairs HDL Intervention Trial
2005
High-Density Lipoprotein Subpopulation Profile and Coronary Heart Disease Prevalence in Male Participants of the Framingham Offspring Study
2004